Levonorgestrel
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00367 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 15 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | acne (disease) | KG + DL |
| 2 | Worth syndrome | KG + DL |
| 3 | pregnancy associated osteoporosis | KG + DL |
| 4 | autosomal dominant neovascular inflammatory vitreoretinopathy | KG + DL |
| 5 | blunt duct adenosis of breast | KG + DL |
| 6 | apocrine adenosis of breast | KG + DL |
| 7 | succinyl-CoA:3-ketoacid CoA transferase deficiency | KG + DL |
| 8 | fat necrosis of breast | KG + DL |
| 9 | breast abscess | KG + DL |
| 10 | lactation disease | KG + DL |
| 11 | breast adenosis | KG + DL |
| 12 | hypoalphalipoproteinemia | KG + DL |
| 13 | complex regional pain syndrome | KG + DL |
| 14 | proliferative vitreoretinopathy | KG + DL |
| 15 | zinc, elevated plasma | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.